Twitter's board put up a defense mechanism against Elon Musk. Here's what he could do next
CNN
Twitter has indicated that it's not interested in being bought by the world's richest man without a fight. The social network's board made a defensive maneuver that could thwart Elon Musk's takeover bid, but he still has a range of options that suggest this Silicon Valley showdown is likely far from over.
Twitter's board said on Friday it was implementing a shareholder rights plan, known as a "poison pill," that would make it harder and more expensive for Musk (or any other would-be buyer) to acquire the company without the board's approval. The plan came a day after Musk made an offer to acquire all the shares in Twitter (TWTR) he does not own for $54.20 a piece, valuing the company at around $41 billion. That represents a 38% premium over Twitter's closing share price the day before Musk's large ownership stake was revealed.
The poison pill plan, detailed in a filing with the Securities and Exchange Commission on Monday, will remain in place for nearly a year and will be triggered if Musk (or any other investor) expands his stake in the company to 15%; he currently owns around 9% of shares. It would give all other shareholders the right to buy one additional share for each share they own at a discount. While other shareholders executing their rights to buy new stock under the plan would have to pay $210 for each new share they purchased, Musk (or another hostile investor) would have to pay $420. (Twitter's team proved Musk isn't the only one capable of spicing up a serious corporate standoff with marijuana references.)
Anesthesiologists are raising alarm about an insurance company’s plan to limit the amount time they cover for anesthesia used in surgeries and procedures. One major professional group of anesthesiologists is calling for immediate reversal of the “unprecedented move,” saying it’s egregious and uninformed.